An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is not effective for this indication. Final…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.